Treatment for Aerobic Vaginitis by Using Bofukang Vaginal Suppository

Launched by PEKING UNIVERSITY SHENZHEN HOSPITAL · Sep 28, 2020

Keywords

ClinConnect Summary

This clinical trial is studying a treatment for aerobic vaginitis, a condition that can cause vaginal discomfort and unusual discharge. The researchers are testing a medication called Baofukang Vaginal Suppository, which participants will use for either 7 or 14 days. The main goal of the trial is to see how well this treatment works and if it is safe for women experiencing this condition.

To be eligible to join the trial, women need to be diagnosed with aerobic vaginitis, which is confirmed by having symptoms like vaginal discharge and a vaginal pH level above 4.5. However, women with other types of vaginitis, certain infections, or serious health conditions, as well as those who are pregnant or breastfeeding, cannot participate. If you join the study, you can expect to use the suppository as directed and attend follow-up appointments to monitor your progress. This trial is currently looking for participants, so if you meet the criteria and are interested, it could be a good opportunity to access a potential new treatment.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Aerobic vaginitis diagnosed based on present ：
• • 1. Vaginal dischareg ;
• • 2. pH \> 4.5;
• • 3. Donders score≥3;
• Exclusion Criteria:
• • 1. Patients with other vaginitis, cervical erosion, or suspected gonorrhea, herpes simplex virus infection and other vulvar diseases;
• • 2. Patients received systemic or vaginal antifungal or antibiotic treatment within two weeks before admission.
• • 3. Pregnancy, lactation and intentional pregnancy;
• • 4. Women with liver and kidney dysfunction, low immune function, diabetes, psychosis or other serious diseases;
• • 5. Allergic constitution and patients allergic to drug ingredients in this study;
• • 6. Those with poor compliance.